Severe Sepsis Completed Phase 3 Trials for Moxifloxacin (DB00218)

Also known as: Sepsis, Severe

IndicationStatusPhase
DBCOND0031268 (Severe Sepsis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00534287Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic ShockTreatment